A carregar...
Non-Drug Costs Associated with Outpatient Infliximab Administration in Pediatric Inflammatory Bowel Disease
BACKGROUND: Infliximab is the most widely used biologic agent for Crohn’s disease (CD) and ulcerative colitis (UC), but requires outpatient infusion units due to its intravenous administration requirement. OBJECTIVES: 1) To determine the average non-drug costs associated with each outpatient use of...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3665698/ https://ncbi.nlm.nih.gov/pubmed/23567783 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MIB.0b013e318281f4f1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|